Pharmacology & Pharmacy
Vol.8 No.3(2017), Paper ID 75244, 20
pages
DOI:10.4236/pp.2017.83007
The Beneficial Effects of Oral Cotrimoxazole upon Likely Biomarkers of Oxidative Stress in Advanced Fibrotic Lung Disease
Veronica Varney, David Salisbury, Helen Parnell, Siva Ratnatheepan, Alex Nicholas, Ginny Quirke, Nazira Sumar, Amolak Bansal
Department of Respiratory Medicine, St Helier Hospital, London, UK
Department of Respiratory Medicine, St Helier Hospital, London, UK
Department of Respiratory Medicine, St Helier Hospital, London, UK
Department of Respiratory Medicine, St Helier Hospital, London, UK
Department of Immunology, St Helier Hospital, London, UK
Department of Respiratory Medicine, St Helier Hospital, London, UK
Department of Immunology, St Helier Hospital, London, UK
Department of Immunology, St Helier Hospital, London, UK
Copyright © 2017 Veronica Varney, David Salisbury, Helen Parnell, Siva Ratnatheepan, Alex Nicholas, Ginny Quirke, Nazira Sumar, Amolak Bansal et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Varney, V. , Salisbury, D. , Parnell, H. , Ratnatheepan, S. , Nicholas, A. , Quirke, G. , Sumar, N. and Bansal, A. (2017) The Beneficial Effects of Oral Cotrimoxazole upon Likely Biomarkers of Oxidative Stress in Advanced Fibrotic Lung Disease.
Pharmacology & Pharmacy,
8, 90-108. doi:
10.4236/pp.2017.83007.